| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr10:50817800-50822200 |
Enhancers |
Pancreas |
Pancrea
|
| 2 |
chr10:50818400-50822400 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
| 3 |
chr10:50818800-50821400 |
Bivalent Enhancer |
Fetal Intestine Small |
intestine
|
| 4 |
chr10:50819200-50821400 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 5 |
chr10:50819200-50821800 |
Bivalent Enhancer |
Brain Hippocampus Middle |
brain
|
| 6 |
chr10:50819400-50821600 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
| 7 |
chr10:50819400-50821800 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 8 |
chr10:50819400-50823000 |
Bivalent Enhancer |
Breast Myoepithelial Primary Cells |
Breast
|
| 9 |
chr10:50819600-50821400 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
| 10 |
chr10:50819600-50821400 |
Bivalent Enhancer |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
| 11 |
chr10:50819600-50822200 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
| 12 |
chr10:50820000-50821800 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 13 |
chr10:50820200-50822000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 14 |
chr10:50820200-50822400 |
Weak transcription |
Right Atrium |
heart
|
| 15 |
chr10:50820800-50821400 |
Bivalent Enhancer |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 16 |
chr10:50820800-50821600 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 17 |
chr10:50820800-50821800 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
| 18 |
chr10:50820800-50821800 |
Bivalent Enhancer |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 19 |
chr10:50820800-50822000 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
| 20 |
chr10:50821000-50821800 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 21 |
chr10:50821000-50821800 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
| 22 |
chr10:50821000-50821800 |
Bivalent Enhancer |
HMEC |
breast
|
| 23 |
chr10:50821000-50822200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 24 |
chr10:50821000-50822400 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 25 |
chr10:50821200-50821400 |
Bivalent Enhancer |
H9 Cell Line |
embryonic stem cell
|
| 26 |
chr10:50821200-50821400 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
| 27 |
chr10:50821200-50821400 |
Bivalent Enhancer |
Brain Cingulate Gyrus |
brain
|
| 28 |
chr10:50821200-50821400 |
Bivalent Enhancer |
Fetal Brain Female |
brain
|
| 29 |
chr10:50821200-50821400 |
Bivalent/Poised TSS |
Placenta |
Placenta
|
| 30 |
chr10:50821200-50821400 |
Flanking Bivalent TSS/Enh |
A549 |
lung
|
| 31 |
chr10:50821200-50821400 |
Flanking Bivalent TSS/Enh |
NHEK |
skin
|
| 32 |
chr10:50821200-50821600 |
Bivalent Enhancer |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 33 |
chr10:50821200-50821600 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
| 34 |
chr10:50821200-50821600 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 35 |
chr10:50821200-50821800 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
| 36 |
chr10:50821200-50821800 |
Flanking Bivalent TSS/Enh |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 37 |
chr10:50821200-50822200 |
Flanking Bivalent TSS/Enh |
HUES48 Cell Line |
embryonic stem cell
|
| 38 |
chr10:50821200-50822200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
| 39 |
chr10:50821200-50822200 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
| 40 |
chr10:50821200-50822800 |
Bivalent/Poised TSS |
Brain Germinal Matrix |
brain
|